openPR Logo
Press release

Nonalcoholic Steatohepatitis (NASH) Market is Expected to Cross US$ 20.0 Billion Globally by 2025

07-03-2017 09:27 AM CET | Health & Medicine

Press release from: Market Research Engine Report

The Nonalcoholic Steatohepatitis market is segmented on the lines of its Therapeutics such as GFT505, Obeticholic Acid (INT-747) Simtuzumab and Liraglutide (Victoza)Vitamin EPioglitazonePlacebo. The Nonalcoholic Steatohepatitis market geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Browse Full Report @: www.marketresearchengine.com/reportdetails/non-alcoholic-...

How Big is the Global Nonalcoholic Steatohepatitis (NASH) Market?

Global Non-Alcoholic Steatohepatitis (NASH) market is expected to cross US$ 20.0 Billion by 2025 growing at a CAGR of more than 10.0% during given forecast period from 2016-2025.

The scope of the report includes a detailed study of global and regional markets for various types of Non alcoholic steatohepatitis with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market.

Table of Contents

1. INTRODUCTION
2. Assumptions and Research Methodology
3. Executive Summary: Global Nonalcoholic Steatohepatitis (NASH) Biomarkers Market
4. Market Overview
5. Global Nonalcoholic Steatohepatitis (NASH) Biomarkers Market Analysis and Forecasts, By Marker Type
6. Global Nonalcoholic Steatohepatitis (NASH) Biomarkers Market Analysis and Forecasts, By End User
7. Global Nonalcoholic Steatohepatitis (NASH) Biomarkers Market Analysis and Forecasts, By Region
8. North America Nonalcoholic Steatohepatitis (NASH) Biomarkers Market Analysis and Forecast
9. Europe Nonalcoholic Steatohepatitis (NASH) Biomarkers Market Analysis and Forecast
10. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Biomarkers Market Analysis and Forecast
11. Latin America Nonalcoholic Steatohepatitis (NASH) Biomarkers Market Analysis and Forecast
12. Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Biomarkers Market Analysis and Forecast
13. Competition Landscape
13.1. Nonalcoholic Steatohepatitis (NASH) Biomarkers Market – Competition Matrix (By Tier and Size of companies) (2015)
13.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.2.1. BioPredictive S.A.S
13.2.2. One Way Liver S.L.
13.2.3. Genfit SA
13.2.4. Quest Diagnostics Incorporated
13.2.5. Prometheus Laboratories Inc. (Part of Nestle Health Sciences)
13.2.6. Siemens Healthcare Private Ltd. (now Siemens Healthineers)
13.2.7. Shenzhen New Industries Biomedical Engineering Co. Ltd. (SNIBE Diagnostics)
13.2.8. Exalenz Biosciences Ltd.

About MarketResearchEngine.com

Market Research Engine is a global market research and consulting organization. We provide market intelligence in emerging, niche technologies and markets. Our market analysis powered by rigorous methodology and quality metrics provide information and forecasts across emerging markets, emerging technologies and emerging business models. Our deep focus on industry verticals and country reports help our clients to identify opportunities and develop business strategies.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862, +91-860-565-7204
Country: United States
Website: www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nonalcoholic Steatohepatitis (NASH) Market is Expected to Cross US$ 20.0 Billion Globally by 2025 here

News-ID: 602786 • Views: 173

More Releases from Market Research Engine Report

3D Printing Materials Market is Expected to Exceed USD 1400 Million by 2020
The 3 D Printing Materials Market is segmented based on material type, form and application. The 3 D Printing Materials Market is segmented based on material type as Plastics, Metals, Ceramics, Others. The 3 D Printing Materials Market is segmented based on form as Filament, Powder, Liquid. The 3 D Printing Materials Market is segmented based on application as Aerospace & defense, Medical & dental, Automotive, Consumer Goods,
Titanium Dioxide Market is Expected to Reach US$ 21 Billion by 2021
The global titanium dioxide market by application is segmented as paints & coatings, pulp & paper, plastics, cosmetics and other applications. The market segments in terms of geographical regions include North America, Europe, Asia-Pacific and Rest of the World (ROW). Browse Full Report @: https://www.marketresearchengine.com/reportdetails/titanium-dioxide-market How Big is the Global Titanium Dioxide Market? Global titanium dioxide market was accounted USD 15.5 billion in 2015. The revenue of this market is anticipated to increase
IoT Healthcare Market in North America is Expected to Grow at CAGR of 43% by 202 …
The IoT healthcare market is divided into technologies and services. The technologies segment is again analyzed by network technologies and applications technologies. The network technologies are further segmented to short range technologies and long-range technologies which are equally vital top form a connected ecosystem of healthcare. The service market is analyzed by consulting, integration and maintenance. The solution segment contributes to a majority part of the market. Browse Full Report
Next Generation Biometrics Market is Expected to Exceed US$ 25 Billion by 2024
Biometrics next generation market is segmented on the lines of its applications, technology and function. The next generation biometric market is segmented on the lines of its technology like face recognition, hand geometry recognition, signature recognition, vein recognition, iris recognition, voice recognition, palm print/hand recognition, fingerprint recognition and DNA recognition. In regards to its function the next generation biometric market wraps contact & non-contact biometrics techniques. Under application segmentation it

All 5 Releases


More Releases for Steatohepatitis

Nonalcoholic Steatohepatitis Therapeutics Market: Trends, and Forecast 2025
According to a new market report published by Transparency Market Research “Nonalcoholic Steatohepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2025”, the nonalcoholic steatohepatitis (NASH) therapeutics market is anticipated to expand at a CAGR of 10.7% from 2015 to 2025 to reach US$20.27 bn by 2025. Nonalcoholic Steatohepatitis (NASH) is a syndrome that advances in patients who are not alcoholic; it causes liver damage
NASH (Non-alcoholic Steatohepatitis) biomarkers - Global Market Outlook (2017-20 …
The latest industry research report on NASH (Non-alcoholic Steatohepatitis) biomarkers by MRC provides a thorough analysis of the global NASH (Non-alcoholic Steatohepatitis) biomarkers market. The report scrutinizes the market by different segments including regions, applications, competitive landscape, etc. over the predicted time frame. This report provides 360 Degree perspective of the NASH (Non-alcoholic Steatohepatitis) biomarkers industry with an all-inclusive discussion of definitions, classifications, and market players in the industry chain
Emerging Opportunities in Nonalcoholic Steatohepatitis Therapeutics Market
Global Nonalcoholic Steatohepatitis (NASH) Market: Snapshot Nonalcoholic Steatohepatitis (NASH), a syndrome found in non-alcoholic patients, causes damage to liver that is histologically akin to alcoholic hepatitis. NASH results from fat in the liver, along with inflammation. Symptoms in NASH usually do not show, but it can be severe and lead to cirrhosis, which is permanent damage to the liver. Those suffering from obesity, dyslipidemia, and glucose intolerance are most likely
Global Non-alcoholic Steatohepatitis Market Research Report 2017
Report Hive Market Research Released a New Research Report of 114 pages on Title " Global Non-alcoholic Steatohepatitis Market Research Report 2017 "with detailed Analysis, Forecast and Strategies. Non-alcoholic greasy liver malady (NAFLD) is one of the sorts of greasy liver which happens when fat is stored (steatosis) in the liver because of causes other than inordinate liquor utilize. NAFLD is the most widely recognized liver issue in created nations. In this
Nonalcoholic Steatohepatitis (NASH) Syndrome - Opportunity Analysis and Forecast …
First described in 1980, Nonalcoholic Steatohepatitis (NASH) (ICD-10-CM = K75.81) is a condition that develops as a subgroup of nonalcoholic fatty liver disease (NAFLD) when excessive fat buildup is accompanied by liver cell injury and inflammation. NAFLD is defined by excessive fat accumulation in the form of triglycerides (steatosis) in the liver. Progression of this condition to NASH dramatically increases the risk of cirrhosis, liver failure, and hepatocellular carcinoma, and
Nonalcoholic Steatohepatitis Therapeutics Market Research Report by Key Players …
According to a new market report published by Transparency Market Research “Nonalcoholic Steatohepatitis Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2025”, the nonalcoholic steatohepatitis (NASH) therapeutics market is anticipated to expand at a CAGR of 10.7% from 2015 to 2025 to reach US$20.27 bn by 2025. Nonalcoholic Steatohepatitis (NASH) is a syndrome that advances in patients who are not alcoholic; it causes liver damage